MedPath
FDA Approval

Akovaz

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 27, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ephedrine(5 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Exela Pharma Sciences, LLC

831274399

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Siegfried Hameln GmbH

Exela Pharma Sciences, LLC

Exela Pharma Sciences, LLC

315869123

Exela Pharma Sciences, LLC

Exela Pharma Sciences, LLC

Exela Pharma Sciences, LLC

831274399

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Akovaz

Product Details

NDC Product Code
51754-4250
Application Number
NDA208289
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
November 27, 2020
EphedrineActive
Code: U6X61U5ZEGClass: ACTIBQuantity: 5 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 9 mg in 1 mL

Akovaz

Product Details

NDC Product Code
51754-4200
Application Number
NDA208289
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
November 27, 2020
EphedrineActive
Code: U6X61U5ZEGClass: ACTIBQuantity: 50 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
ACETIC ACIDInactive
Code: Q40Q9N063PClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath